Caricamento...
Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
BACKGROUND AND AIM: It is unclear how adding an anti‐tumor necrosis factor alpha agent to immunomodulator (IM) treatment, as a step‐up strategy, affects long‐term outcomes in ulcerative colitis. This retrospective study investigated persistence associated with biologic anti‐tumor necrosis factor alp...
Salvato in:
| Pubblicato in: | J Gastroenterol Hepatol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7027773/ https://ncbi.nlm.nih.gov/pubmed/31397010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.14825 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|